Previous 10 | Next 10 |
The following slide deck was published by MediWound Ltd. in conjunction with this Read more ...
Eastman Kodak Company (NYSE: KODK ) +42% as independent review says no laws were broken. More news on: Eastman Kodak Company, Myomo, Inc., Pacific Ethanol, Inc., Stocks on the move, , Read more ...
MediWound (NASDAQ: MDWD ) and exclusive North America licensee Vericel (NASDAQ: VCEL ) have announced that the FDA has accepted marketing application seeking approval of NexoBrid for eschar removal (debridement) in adults with deep partial-thickness and/or full-thickness thermal b...
YAVNE, Israel, Sept. 16, 2020 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD) (the “MediWound”), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, today announced that the U.S. Food and Drug...
MediWound ( MDWD ) has popped up on my scanner several times over the past couple of years following some potent company press releases and catalysts. Admittedly, I would take a look at the headline and then check the ticker only to see a big move followed by a fade, so I have failed to actual...
YAVNE, Israel, Sept. 03, 2020 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD) (the “Company”), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, today announced that Sharon Malka, MediWound&...
MediWound (NASDAQ: MDWD ) and exclusive North America licensee Vericel (NASDAQ: VCEL ) a nnounces acceptance of the first delivery of NexoBrid valued at $16.5M to Biomedical Advanced Research and Development Authority (BARDA). More news on: MediWound Ltd., Vericel Corporation, He...
YAVNE, Israel and CAMBRIDGE, Mass., Aug. 25, 2020 (GLOBE NEWSWIRE) -- MediWound Ltd. (NASDAQ: MDWD) and its U.S. commercial partner Vericel Corporation (NASDAQ: VCEL) today announced that the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant...
Mediwound Ltd (MDWD) Q2 2020 Earnings Conference Call August 06, 2020, 08:30 ET Company Participants Jeremy Feffer - LifeSci Advisors Sharon Malka - CEO Boaz Gur-Lavie - CFO Conference Call Participants Kevin DeGeeter - Oppenheimer Swayampakula Ramakanth - H.C. Wainwright...
MediWound (NASDAQ: MDWD ) : Q2 GAAP EPS of -$0.11 beats by $0.01 . More news on: MediWound Ltd., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , Read more ...
News, Short Squeeze, Breakout and More Instantly...
Funds to be used for clinical development of EscharEx ® to treat diabetic foot ulcers (DFUs) Award advances MediWound’s DFU program and its future revenues four years ahead of original schedule YAVNE, Israel, July 16, 2024 (GLOBE NEWSWIRE) -- MediWound Ltd....
Mölnlycke® Health Care announces US $15m investment in next-generation enzymatic therapeutics company MediWound Ltd PR Newswire GOTHENBURG, Sweden , July 15, 2024 /PRNewswire/ -- Mölnlycke Health Care, a world-leading MedTech company specialising i...
YAVNE, Israel, July 15, 2024 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), the world leader in next-generation enzymatic therapeutics for tissue repair, today announced it has entered into a definitive share purchase agreement with several new and existing investors, including Mölnlycke...